Copenhagen, 2016-05-19 14:52 CEST (GLOBE NEWSWIRE) -- QIAGEN N.V., Company reg. no. 804803778, published a Recommended Public Conditional Voluntary Offer on 19 April 2016 (the "Offer") to the shareholders of Exiqon A/S, Company reg. no. (CVR) 18984431.
According to the Offer, the Offer Period expired yesterday on 18 May 2016 at 23.59 (CET). In accordance with Section 9 and 21 of the Danish Takeover Order and as set forth in the Offer Document, QIAGEN N.V. hereby announces the preliminary result of the Offer and QIAGEN N.V.’s decision to extend the Offer Period until 2 June 2016 at 23.59 (CET). All other terms and conditions of the Offer are unchanged.
The preliminary and non-binding counting of the acceptances shows that QIAGEN N.V. in total has received acceptances from shareholders in Exiqon A/S representing 81.37% of the share capital and voting rights in Exiqon A/S.
The extension of the Offer Period and the conditions thereof is set out in the attached supplement to the Offer Document.
"We are confident that not only Exiqon’s board of directors and the largest shareholders appreciate our compelling and fair offer, but also all other shareholders”, commented Peer Schatz, CEO of QIAGEN N.V. “We realize that some shareholders may need more time to review the offer. We trust that in the end they will recognise that the offer values the company appropriately, and that we will reach the 90% acceptance rate necessary to complete the transaction.”
Unless the Offer Period is once more extended, QIAGEN N.V. will announce the preliminary result of the Offer through the Danish FSA, NASDAQ Copenhagen and through electronic media no later than eighteen hours after expiry of the Offer Period, i.e. on 3 June 2016. The Offeror will announce the final result of the Offer on or before 6 June 2016, which is three days after the completion of the Offer. See Section 21(3) of the Danish Takeover Order.
Definitions applied but not specified in this announcement shall have the same meaning as set out in the Offer Document.
